SightfileU.S. market data from official filings

Companies › AURX

NUO THERAPEUTICS INC (AURX)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001091596 · EDGAR filings · Updated 2026-07-02

NUO THERAPEUTICS INC (AURX) has 1 institutional managers reporting positions valued at $6.82K per the latest 13F reporting period. SEC filings include an active substantial-doubt (going concern) disclosure per the filings.

Institutional managers
1
Reported 13F value
$6.82K
Insider activity
21 trans.
−$100.0K net selling
Data flags
1 active
from SEC filings

Latest updates

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, NUO THERAPEUTICS INC has 1 institutional holders.

Insider activity

Insiders reported 21 transactions (1 buys, 1 sells) across 6 reporting insiders, with a net reported value of −$100.0K.

Data flags from SEC filings

Active substantial-doubt (going concern) disclosure per the filings, most recently filed 2026-05-14 (recurring since 2020-01-31) — source filing. The authoritative details are those stated in the filing itself.

Related companies

AYR Wellness Inc. (AYRWF) · United Health Prods Inc COM (UEEC) · CLEARSIDE BIOMEDICAL INC (CLSDQ) · XORTX THERAPEUTICS INC (XRTX) · VIREO GROWTH INC (VREOF) · Kaya Holdings, Inc. (KAYS)

See full history, cross-references and alerts on Sightfile
Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-02.